Skip to main content
Premium Trial:

Request an Annual Quote

Danish Firm Nuevolution Lends Screening Technology to Epigenetics Therapeutics Project

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danish drug discovery firm Nuevolution today said it will employ its screening technology as part of a consortium to identify and develop small molecule drugs against epigenetic disorders.

Nuevolution, based in Copenhagen, Denmark, joins the consortium that also includes EpiTherapeutics, ExpreS2ion Biotechnologies, and the research group of Kristian Helin at the Biotech Research & Innovation Centre at the University of Copenhagen.

For the collaboration, Nuevolution will use its Chemetics high-throughput and fragment-based screening technology to screen hundreds of millions of small molecules, it said in a statement. The Chemetics platform enables rapid synthesis and DNA tagging of hundreds of millions of chemically diverse drug-like small molecule compounds, said Nuevolution.

The other members will provide biology and disease expertise.

The DKK24 million ($4.5 million) project is being funded by the Danish High Technology Fund.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.